anti-infective


Also found in: Dictionary, Thesaurus, Encyclopedia.

anti-infective

(ăn′tē-ĭn-fĕk′tĭv, ăn′tī-)
adj.
Capable of preventing or counteracting infection.
n.
An anti-infective substance.

anti-infective

adjective Referring to an agent or mechanism that counters an infection.

noun An uncommonly used synonym for an antibiotic or antimicrobial.

anti-infective

(ant″ē-in-fek′tiv) [ anti- + L. inficere, to corrupt, to infect]
1. Tending to combat infection.
2. An agent, such as an antibiotic, antifungal, or antiviral drug, that combats infection.
References in periodicals archive ?
Global Anti-Infective Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.
We are very confident that the unique macrocycles produced through our versatile CMRT Technology combined with the superb research team at AiCuris offer excellent potential for the discovery and development of novel anti-infective therapeutics.
* XW043G4 Introduction of Plazomicin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 4
Primary care treatment with anti-infective drugs - indicating the presence of common, less-severe infections was unrelated to the chances of completing ninth grade.
"The introduction of Moxifloxacin expands both our leading anti-infective portfolio and our ready-to-use intravenous offerings in the U.S."
A number of corporate research teams in the Boston-Cambridge area, a major hub for research on anti-infective drugs, have recently announced cuts of several hundred scientists and other staffers.
Monrovia, CA, May 11, 2014 --(PR.com)-- John Rex, Vice President and Head of Infection, Global Medicines Development at AstraZeneca will be a speaker and panelist at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA, by GTCBio.
Anti-infective surfaces are also said to have a crucial role in helping to combat the threat of antimicrobial resistance to potentially deadly infections such as MRSA.
Haverfield pledged that PhRMA is prepared to work with the FDA and other stakeholders toward establishment "of an appropriate and targeted regulatory approach that will accelerate the development and availability of novel antibiotic and anti-infective medicines."
"The snapshots we've taken of the molecules can provide valuable guidance for the development of new anti-cancer and anti-infective drugs," Dr Wagner added.
The approval comes as no surprise, as the orphan drug was seen as an urgently needed therapeutic to treat the respiratory and pulmonary symptoms of CE and led the FDA's Anti-Infective Drugs Advisory Committee to overwhelmingly support approval of Cayston (aztreonam for inhalation solution).